| Follow Us:

Innovation & Job News

Noxilizer Expands Medical Device Production

Noxilizer Inc. expects to more than double its manufacturing capacity of its proprietary sterlization units for medical devices, thanks to its recent move to a larger production facility.
Maura Kahn, vice president business development and marketing, says Noxilizer’s relocation from the incubator at University of Maryland, Baltimore County to the University of Maryland, BioPark in downtown Baltimore allows the company to manufacture five to six units, rather than one to two, per year. Kahn says customers include medical device manufacturers, biotechnology and pharmaceutical companies, such as the Catheter Research Center in Indianapolis.
“We have roughly the same amount of office space but double the laboratory space. Moving to a larger lab facility allows us to expand our microbiology operations and to build our sterilization units,” Kahn says.
Noxilizer’s manufactures its RTS 360 Sterilization Unit on premise, with subcontractors in Maryland completing the assembly. The first units went on sale in 2011. The units employ a gas-based, room temperature process that allows them to be used for new medical devices that can’t be sterilized by the traditional method.
Noxilizer’s sterilization units cost $250,000 each. The company offers a three-year service contract for $40,000.  To run the unit, customers purchase sterilants from Noxilizer at a typical cost of $2000 to $2500 per month.
Noxilizer, a privately-held company, was founded in 2004. It originally had offices in both Bethesda and Baltimore. In 2010, the two offices were combined into one and moved into the incubator [email protected]
The company employs 19 full-time and two part-time workers. Last year, it added six new employees and is currently looking to hire a director of quality. The company also employs four-to-six paid interns per year, usually from the University of Maryland Baltimore County and Stevenson University, who are often hired as full-time employees after graduation.
Noxilizer recently raised $3.5 million in a financing round via the Maryland Biotechnology Investment Tax Credit program. It also received $500,000 from The Abell Foundation. Last year, the company was named Maryland Incubator Company of the Year in the life sciences category.
Source: Maura Kahn, Noxilizer Inc.
Writer: Barbara Pash
Signup for Email Alerts
Share this page
Signup for Email Alerts